RxDoctor Payments Data

Aristides Assimacopoulos, MD

Internal Medicine · Rocky Mount, NCNPI 1720054950

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 15th percentile of 3,302 internal medicine providers in North Carolina.

See all internal medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$554,463
Medicare patients
359
Services billed
4,585

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Daptomycin11$4,611
CeftriaxoneCeftriaxone Sodium15$520
Alfuzosin Hcl ErAlfuzosin Hcl12$469

Paid to pharmacies, not to this prescriber.

Other internal medicine in Rocky Mount

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →